Dmitry Balyasny’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Dmitry Balyasny’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-9,440	Closed	-$223K	–	1757
2015 Q4	$223K	Buy	+9,440	New	+$104K	﹤0.01%	1070

Other funds holding KBIO

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Dmitry Balyasny's KBIO Position: Q1 2016 in Review

Dmitry Balyasny sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2016, closing a stake of 9,440 shares — an estimated $223K sold.

Dmitry Balyasny first reported a position in KBIO in Q4 2015 and held it in 1 quarter. The position peaked at $223K in Q4 2015. 1 fund tracked by Wall St. Rank holds KBIO as of Q1 2016.

Dmitry Balyasny reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2016 after selling out during the quarter.
Dmitry Balyasny sold 9,440 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2016, an estimated $223K.
Dmitry Balyasny first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q4 2015 and held it in 1 quarter.
Dmitry Balyasny's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $223K in Q4 2015.
1 fund tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2016.

Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.